Navigation Links
Miscarriage linked to late embryos

The later a fertilised egg implants in a woman's uterus, the more likely she is to have a miscarriage, new research has found.The report in the latest New England Journal of Medicine details the most precise information the timing of implantation - the true start of pregnancy - influences its success or failure.

Fertilised eggs can attach themselves to the lining of the womb anywhere from six to 12 days after ovulation, the researchers from the National Institute of Environmental Health Sciences found.But most successful pregnancies implant eight, nine or ten days after the egg's release from the ovary, with those implanting on day eight having the greatest chance of success.//

The researchers speculate that late-implanting embryos may be weaker and that rejection of them may be a protective mechanism designed to spare the mother the physiologic burden of supporting non-viable offspring.

The new studies, which monitored the hormones in daily urine samples of healthy women trying to conceive, showed the day by day trend for the first time in a large sample (341 women). The work showed 12 per cent of pregnancies failed if implantation occurred by the ninth day, but the figure rose to 26 per cent when implantation occurred on the 10th day, 52 per cent on the 11th day and 82 per cent thereafter.The researchers found no association between late implantation and clinical miscarriages that occurred later in pregnancy.


'"/>




Page: 1

Related medicine news :

1. Hormone Deficiency Results In Miscarriage
2. Miscarriage during pregnancy and heart disease linked
3. Painkillers Increase Risk of Miscarriage
4. Low Protein Levels A Possible Indicator For A Miscarriage
5. New Findings for Repeated Miscarriages
6. Naturally Occurring Hormone Can Lead To Miscarriage
7. Medical Management Now Available For Miscarriage
8. Drugs As Alternative To Surgery After Miscarriage
9. DNA Identity Mix-Up In Bone Marrow Donors, And Miscarriages Of Justice Involved
10. Early Miscarriage Common In Women Under Stress
11. Immune-Boosting Therapies Of No Use In Preventing Miscarriage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: